Orchid Island Capital announced a monthly dividend of $0.10 per share for October 2026, payable in November. The company reported an estimated GAAP net loss of $0.90 per share for Q3 2026, driven by $1.17 per share in losses on RMBS and derivatives. Its estimated book value per share stood at $6.02 as of September 30, 2026, with a total return on equity of -12.5% for the quarter. Orchid Island plans to continue monthly dividends but noted that future payments depend on taxable income and market conditions.
Orchid Island Capital announced its October 2026 monthly dividend and estimated third quarter results. For readers following the Real Estate sector, here is Pluang's market snapshot as of Oct 15, 2026 02:21 WIB: out of 47 priced US Real Estate stocks, 13 rose and 34 fell. Notable movers include IRM at USD 111.08 with a -3.07% change, AIV at USD 1.68 with -2.89%, and DLR at USD 173.12 with -2.82%.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
